-10.01% percent quarterly performance for Regeneron Pharmaceuticals, Inc (REGN) is not indicative of the underlying story
Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) on Friday, soared 2.65% from the previous trading day, before settling in for the closing price of $590.00. Within the